Navigation Links
ATS Medical Announces First 'Frontiers in Cryoablation' Symposium
Date:4/30/2008

Event is Co-Sponsored by Intuitive Surgical and ATS Medical

MINNEAPOLIS, April 30 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced the first Frontiers in Cryoablation Symposium to be held at the American Association for Thoracic Surgery Annual Meeting in San Diego. The symposium is the first in a series of meetings intended to further the evolution and direction for cryoablation therapy, a treatment for atrial fibrillation. Dr. James L. Cox, inventor of the Maze procedure and Medical Director for ATS Medical, will lead the symposia series. The program will include a preeminent faculty of cardiac surgeons reporting on current techniques, robotics, and the future of minimally invasive cryoablation utilizing the ATS CryoMaze(TM) Surgical Ablation System.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040202/ATSILOGO)

This first symposium, titled "Current Techniques, Robotics and the Future of Minimally Invasive Cryoablation" is sponsored collaboratively by ATS Medical and Intuitive Surgical, the makers of the da Vinci(R) Surgical System (Nasdaq: ISRG). The symposium follows the recent market release of Intuitive Surgical's Endowrist Cardiac Probe Grasper -- a device specifically designed to assist the da Vinci System in manipulating ATS CryoMaze Surgical Ablation Probes to complete the Cox Maze III procedure
'/>"/>

SOURCE ATS Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Medical journal calls upon Barack Obama to do much more
2. ACP hosts largest medical education meeting for general and subspecialty internists
3. Flashpoint Medica Named Agency of Year by Medical Advertising News
4. Virginia Judge Rules Medical Device Pioneer Committed Malpractice
5. Digirad Corporation and University of Chicago Medical Center Sign Letter of Agreement
6. PSI Corp. Announces Additional Hospitals and Medical Office Buildings to Utilize Its Digital Signage Network
7. Labopharm Appoints Dr. Claire Brulle as Senior Vice-President and Chief Medical Officer
8. J. Greg Davis Appointed President & Chief Executive Officer of Tryton Medical, Inc.
9. Story of Womans Courage and Medical Innovation Top Choice for Readers
10. Houston Northwest Medical Center Caregiver Honored by Tenet Healthcare
11. Oaks Development Group Acquires Medical Office Building in Punta Gorda, Florida
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2014)... negative and stressful outcomes for parents who have a ... illness, says a recent study led by a researcher ... are numerous and life-changing and stress levels high, the ... research reported positive outcomes as well, a phenomenon known ... recent issue of the American Journal of Orthopsychiatry ...
(Date:4/24/2014)... 2014 ,Take me out to the ballgame, doesn,t ... chips. The more likely culprits include French fries, soda ... for children who play youth baseball, eating unhealthy food ... problems, according to researchers at Wake Forest Baptist Medical ... of Childhood Obesity , found that high-calorie snacks ...
(Date:4/24/2014)... will bring together national experts to discuss solutions ... inaugural Brain Health Summit, titled "The Human Brain: ... Dr. Sandra Bond Chapman, founder and chief director ... Grassley (R-IA), U.S. Representative Chaka Fattah (D-PA) and ... Early Learning, U.S. Department of Education. The day ...
(Date:4/24/2014)... Fibroblasts, cells long thought to be boring and irrelevant, ... with heart disease. , Researcher Dr Milena Furtado, and ... at Monash University, found the heart cell fibroblast is ... for a healthy beating heart. , In research published ... found that cardiac fibroblasts are unique cells due to ...
(Date:4/24/2014)... of prescription opioid overdose deaths was outlined yesterday in ... leaders of agencies in the U.S. Department of Health ... care providers to expand their use of medications to ... a number of misperceptions that have limited access to ... medications can be used in combination with behavior therapies ...
Breaking Medicine News(10 mins):Health News:Parents of severely ill children see benefits as caregivers, says study 2Health News:Take the bat, leave the candy 2Health News:Inaugural Brain Health Summit focuses on brain resilience and regeneration 2Health News:Boring cells could hold the key to heart disease 2Health News:HHS leaders call for expanded use of medications to combat opioid overdose epidemic 2Health News:HHS leaders call for expanded use of medications to combat opioid overdose epidemic 3Health News:HHS leaders call for expanded use of medications to combat opioid overdose epidemic 4
... The California Veterinary Medical Association (CVMA) warns ... when procedures such as teeth cleaning or therapeutic ... is because special training is necessary and some ... and may require anesthesia. Under California law, only ...
... someday yield therapies to restore sight, experts suggest , , ... plays a major role in two forms of childhood ... researchers. , The discovery of the link between the ... retinitis pigmentosa is important because it pinpoints a new ...
... experts warn , , THURSDAY, March 5 (HealthDay News) -- ... have positive or neutral attitudes toward people who are ... prospective patients, a new study has found. , "Essentially, ... weight bias, and there are negative attitudes toward obese ...
... a national provider of healthcare information technology outsourcing, ... Total Security Program which is designed to offer ... of security services that assess, remediate and monitor ... The Program goes beyond regulated compliance requirements to ...
... Realize New Executive LeadershipKOBE, Japan, March 5 ... leading medical diagnostics instrument manufacturer and laboratory information ... Sysmex Corporate and its subsidiaries in the Americas, ... Kazuya Obe will return to Sysmex Corporate after ...
... headed by Dr. Tom Feasby, Dean of UCalgary,s Faculty ... countries in the number of diagnostic imaging devices, more ... times. The study,s authors say it is critical to ... "This study shows there are important deficiencies in the ...
Cached Medicine News:Health News:Consumers Beware: Unlicensed Care of Animals May Cause Health Problems and Increased Costs 2Health News:Retinal Gene Is Linked to Childhood Blindness 2Health News:Bias Against Obesity Is Found Among Future Dietitians 2Health News:Bias Against Obesity Is Found Among Future Dietitians 3Health News:Phoenix Health Systems Launches Total Security Program for the Healthcare Industry 2Health News:Sysmex Corporation Announces Organizational Changes 2Health News:Lack of strategies to manage MRI wait lists a key reason for excessive wait times 2
(Date:1/14/2014)... , Jan. 14, 2014 HeartWare International, ... innovator of less invasive, miniaturized circulatory support technologies that ... announced that it expects revenues for the fourth quarter ... full-year 2013 revenues to approximately $208 million. ...
(Date:1/14/2014)... Dynamic Healthcare Services, Inc. ("DHS"), a portfolio company of ... Home Medical Equipment, Inc. ("Progressive") of Clarion, PA ... acquisition were not disclosed. Progressive is a ... range of sleep, mobility, and respiratory products to customers in ...
(Date:1/14/2014)... Jan. 14, 2014 NineSigma , Inc., the ... Innovation Leadership Summit , May 14-16, 2014 at ... Cleveland Ohio . This is ... committed to breakthrough achievements through open innovation. Participants will ...
Breaking Medicine Technology:HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 4
... Medical, Inc. (Nasdaq: NXTM ), a leading manufacturer ... financial results for the first quarter ended March 31, 2011 ... financial markets. NxStage will also host a conference ... 2011 to discuss its first quarter financial results. To listen ...
... Novartis Pharmaceuticals Corporation ("Novartis") announced today that the ... Advisory Committee (ODAC) recommended approval of Afinitor® (everolimus) ... neuroendocrine tumors (NET) of pancreatic origin. ... from the everolimus RADIANT (RAD001 In Advanced Neuroendocrine ...
Cached Medicine Technology:NxStage® to Report First Quarter Fiscal 2011 Financial Results 2Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 2Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 3Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 4Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 5Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 6Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 7Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 8Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 9Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 10
... a vacuum tube for the collection, transport ... immunophenotyping by flow cytometry. The preservative contained ... the white blood cell cluster of differentiation ... Patient samples collected in Cyto-Chex BCT are ...
Streck-ONYX-Pack is specially designed for use on Coulter® ONYX Series instruments. Each pack contains diluent and lysing agent. The shelf life is one year from date of manufacture....
... reagent manufactured for the simultaneous quantitative ... cells. Streck-Lysing Agent IIIC is for ... S Plus II, III, IV, V, ... JT Series. The shelf life is ...
Streck-CD3500 Hemoglobin/Lyse is a lytic reagent for the quantitative determination of hemoglobin on the Abbott CELL-DYN® 3500 and 3700. The shelf life is two years from the date of manufacture....
Medicine Products: